Finance

Beta
Lists
ADXN:NASDAQ
Addex Therapeutics Ltd - ADR
$6.40
0.00%
(0.00) 1D
Jun 2, 11:41:08 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ADXN...
Mkt. cap
12.78M
Avg. vol.
3.28K
Volume
353.00
52-wk high
$12.05
52-wk low
$5.41
EPS
-$9.72
Beta
1.49
Shares outstanding
1.82M
No. of employees
3
Mkt. cap
12.78M
Avg. vol.
3.28K
Volume
353.00
52-wk high
$12.05
52-wk low
$5.41
EPS
-$9.72
Beta
1.49
Shares outstanding
1.82M
No. of employees
3
News stories
From sources across the web
About Addex Therapeutics Ltd - ADR
CEO-
Employees3
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
71.06K
36.38K
49.60K
15.83K
Cost of goods sold
156.07K
234.45K
228.32K
51.84K
Cost of revenue
156.07K
234.45K
228.32K
51.84K
Research and development expenses
-
-
-
970.00
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
521.25K
534.82K
517.45K
742.28K
Operating expense
521.25K
534.82K
517.45K
743.25K
Total operating expenses
677.32K
769.27K
745.78K
795.09K
Operating income
-606.26K
-732.90K
-696.18K
-779.26K
Other non operating income
-
-
-
-
EBT including unusual items
-1.47M
-1.96M
-1.58M
-1.83M
EBT excluding unusual items
-1.47M
-1.96M
-1.58M
-1.83M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.47M
-1.84M
-1.58M
-1.84M
Net profit margin
-2,072.85%
-5,061.62%
-3,179.90%
-11,604.47%
Earnings per share
-
-
-
-
Interest and investment income
-
3.00
-
-
Interest expense
-548.00
-829.00
-472.00
-575.00
Net interest expenses
-548.00
-826.00
-472.00
-575.00
Depreciation and amortization charges
-
-
-
-
EBITDA
-604.14K
-730.78K
-696.07K
-779.16K
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more